Impurities found in certain angiotensin II receptor blocker (ARB) products

January 8, 2019

Health Canada has provided an update regarding the ARB/valsartan products recall that occurred in the summer of 2018. Information related to the impurities identified, a complete recalled product list, and testing results of various ARB products is provided in the update. For details, visit the Health Canada website.

← Previous ArticleNext Article →